DK138328C

Hexahydroindolo[2,3-a]quinolizine derivatives of the formula (I) are prepared by reacting a compound of the formula (II) with acrylonitrile. The base obtained in this way can, where appropriate, be converted by treatment with an acid into the corresponding salt. This salt can be treated with a relat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FARKAS M, SZABO L, KEVE T, KALAUS G, STEFKO B, LAKSZNER K, KREIDL J, RANKY K, SZANTAY C
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FARKAS M
SZABO L
KEVE T
KALAUS G
STEFKO B
LAKSZNER K
KREIDL J
RANKY K
SZANTAY C
description Hexahydroindolo[2,3-a]quinolizine derivatives of the formula (I) are prepared by reacting a compound of the formula (II) with acrylonitrile. The base obtained in this way can, where appropriate, be converted by treatment with an acid into the corresponding salt. This salt can be treated with a relatively strong base in order to liberate the hexahydroindoloquinolizine base of the formula (Ib). The symbols used in the formulae have the meanings stated in Claim 1. The compounds are important starting materials for the preparation of, in particular, indoloquinolizine derivatives which have a vasodilator effect.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK138328CC</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK138328CC</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK138328CC3</originalsourceid><addsrcrecordid>eNrjZOB08TY0tjA2snDmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxcPXOxoRVAACmgBpP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DK138328C</title><source>esp@cenet</source><creator>FARKAS M ; SZABO L ; KEVE T ; KALAUS G ; STEFKO B ; LAKSZNER K ; KREIDL J ; RANKY K ; SZANTAY C</creator><creatorcontrib>FARKAS M ; SZABO L ; KEVE T ; KALAUS G ; STEFKO B ; LAKSZNER K ; KREIDL J ; RANKY K ; SZANTAY C</creatorcontrib><description>Hexahydroindolo[2,3-a]quinolizine derivatives of the formula (I) are prepared by reacting a compound of the formula (II) with acrylonitrile. The base obtained in this way can, where appropriate, be converted by treatment with an acid into the corresponding salt. This salt can be treated with a relatively strong base in order to liberate the hexahydroindoloquinolizine base of the formula (Ib). The symbols used in the formulae have the meanings stated in Claim 1. The compounds are important starting materials for the preparation of, in particular, indoloquinolizine derivatives which have a vasodilator effect.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>1979</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19790122&amp;DB=EPODOC&amp;CC=DK&amp;NR=138328C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19790122&amp;DB=EPODOC&amp;CC=DK&amp;NR=138328C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FARKAS M</creatorcontrib><creatorcontrib>SZABO L</creatorcontrib><creatorcontrib>KEVE T</creatorcontrib><creatorcontrib>KALAUS G</creatorcontrib><creatorcontrib>STEFKO B</creatorcontrib><creatorcontrib>LAKSZNER K</creatorcontrib><creatorcontrib>KREIDL J</creatorcontrib><creatorcontrib>RANKY K</creatorcontrib><creatorcontrib>SZANTAY C</creatorcontrib><title>DK138328C</title><description>Hexahydroindolo[2,3-a]quinolizine derivatives of the formula (I) are prepared by reacting a compound of the formula (II) with acrylonitrile. The base obtained in this way can, where appropriate, be converted by treatment with an acid into the corresponding salt. This salt can be treated with a relatively strong base in order to liberate the hexahydroindoloquinolizine base of the formula (Ib). The symbols used in the formulae have the meanings stated in Claim 1. The compounds are important starting materials for the preparation of, in particular, indoloquinolizine derivatives which have a vasodilator effect.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1979</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOB08TY0tjA2snDmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxcPXOxoRVAACmgBpP</recordid><startdate>19790122</startdate><enddate>19790122</enddate><creator>FARKAS M</creator><creator>SZABO L</creator><creator>KEVE T</creator><creator>KALAUS G</creator><creator>STEFKO B</creator><creator>LAKSZNER K</creator><creator>KREIDL J</creator><creator>RANKY K</creator><creator>SZANTAY C</creator><scope>EVB</scope></search><sort><creationdate>19790122</creationdate><title>DK138328C</title><author>FARKAS M ; SZABO L ; KEVE T ; KALAUS G ; STEFKO B ; LAKSZNER K ; KREIDL J ; RANKY K ; SZANTAY C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK138328CC3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1979</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>FARKAS M</creatorcontrib><creatorcontrib>SZABO L</creatorcontrib><creatorcontrib>KEVE T</creatorcontrib><creatorcontrib>KALAUS G</creatorcontrib><creatorcontrib>STEFKO B</creatorcontrib><creatorcontrib>LAKSZNER K</creatorcontrib><creatorcontrib>KREIDL J</creatorcontrib><creatorcontrib>RANKY K</creatorcontrib><creatorcontrib>SZANTAY C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FARKAS M</au><au>SZABO L</au><au>KEVE T</au><au>KALAUS G</au><au>STEFKO B</au><au>LAKSZNER K</au><au>KREIDL J</au><au>RANKY K</au><au>SZANTAY C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DK138328C</title><date>1979-01-22</date><risdate>1979</risdate><abstract>Hexahydroindolo[2,3-a]quinolizine derivatives of the formula (I) are prepared by reacting a compound of the formula (II) with acrylonitrile. The base obtained in this way can, where appropriate, be converted by treatment with an acid into the corresponding salt. This salt can be treated with a relatively strong base in order to liberate the hexahydroindoloquinolizine base of the formula (Ib). The symbols used in the formulae have the meanings stated in Claim 1. The compounds are important starting materials for the preparation of, in particular, indoloquinolizine derivatives which have a vasodilator effect.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_DK138328CC
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title DK138328C
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T17%3A19%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FARKAS%20M&rft.date=1979-01-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK138328CC%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true